cholecystokinin 33 (10-20) has been researched along with pilocarpine in 1 studies
*Pilocarpine: A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma. [MeSH]
*Pilocarpine: A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma. [MeSH]
| Studies (cholecystokinin 33 (10-20)) | Trials (cholecystokinin 33 (10-20)) | Recent Studies (post-2010) (cholecystokinin 33 (10-20)) | Studies (pilocarpine) | Trials (pilocarpine) | Recent Studies (post-2010) (pilocarpine) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 7,334 | 340 | 1,528 |
| Protein | Taxonomy | cholecystokinin 33 (10-20) (IC50) | pilocarpine (IC50) |
|---|---|---|---|
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 3.0267 | |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 3.84 | |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 3.84 | |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 3.84 | |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 3.84 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantor, P; Holst, JJ; Knuhtsen, S; Rehfeld, JF | 1 |
1 other study(ies) available for cholecystokinin 33 (10-20) and pilocarpine
| Article | Year |
|---|---|
Effect of neuroactive agents on cholecystokinin release from the isolated, perfused porcine duodenum.
Topics: Animals; Atropine; Cholecystokinin; Duodenum; Gastrin-Releasing Peptide; Peptide Fragments; Peptides; Perfusion; Physostigmine; Pilocarpine; Radioimmunoassay; Swine | 1987 |